Approximately USD 500bn worth of M&A deals are waiting to happen. SGA can assist you in tapping into the right audience, tech due diligence, and healthcare intel, along with cutting down the lag phase from search to go to market.
We, at SG Analytics (SGA), are different, as our team of experts believes in end-to-end solutions for M&A firms and are largely based on the process lifecycle. The healthcare mergers and acquisition consulting team assists clients with intelligence gathering, strategy identification, and peer deal alerts. Our analysts can assist with therapeutic-specific content, tech-specific content, tech penetration analysis, and market forecasts. We work in unison with the investment research team of SGA, which supports us with the required due diligence. Together as a team, we are unmatched and unstoppable.
M&A firms and venture capitalists are on the lookout for new technologies and acquirers from developing and developed worlds in the pharmaceutical, life sciences, and devices segments. We specialize in identifying and analyzing new medical technology, patent cliffs, patent conflicts, new FDA and ANDA filings, peer competition, and more.
Why SGA
Industry Leaders
SGA thrives by its brand promise Life is Possible, and is deemed as the most trusted healthcare market research consulting company.
12+ Languages
SGAs language capabilities involve Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (US/UK).
Data-Driven Insights
With our in-depth domain knowledge, expertise, and proven capabilities of delivering monetizable insights, we provide high-quality, efficient outputs.
End-To-End Solutioning
The in-house key opinion leader (KOL) capability of more than 700, along with analytical and ML/AI capabilities, helps in offering incredible competitive information.
White Papers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
White Papers
The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?
Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....
White Papers
What Happens When You Invest in Healthcare Consulting and Analytics?
Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...
We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
